Suppr超能文献

抗肥胖药用植物和植物化学物质的代谢与表观遗传学作用机制

Metabolic and Epigenetics Action Mechanisms of Antiobesity Medicinal Plants and Phytochemicals.

作者信息

Saad Bashar, Ghareeb Bilal, Kmail Abdalsalam

机构信息

Faculties of Medicine and Arts and Sciences, Arab American University, P.O. Box 240, Jenin, State of Palestine.

Qasemi Research Center, Al-Qasemi Academy, P.O. Box 124, 30100 Baqa Al-Gharbia, Israel.

出版信息

Evid Based Complement Alternat Med. 2021 Jun 9;2021:9995903. doi: 10.1155/2021/9995903. eCollection 2021.

Abstract

Ever-growing research efforts are demonstrating the potential of medicinal plants and their phytochemicals to prevent and manage obesity, either individually or synergistically. Multiple combinations of phytochemicals can result in a synergistic activity that increases their beneficial effects at molecular, cellular, metabolic, and temporal levels, offering advantages over chemically synthesized drug-based treatments. Herbs and their derived compounds have the potential for controlling appetite, inhibiting pancreatic lipase activity, stimulating thermogenesis and lipid metabolism, increasing satiety, promoting lipolysis, regulating adipogenesis, and inducing apoptosis in adipocytes. Furthermore, targeting adipocyte life cycle using various dietary bioactives that affect different stages of adipocyte life cycle represents also an important target in the development of new antiobesity drugs. In this regard, different stages of adipocyte development that are targeted by antiobesity drugs can include preadipocytes, maturing preadipocytes, and mature adipocytes. Various herbal-derived active compounds, such as capsaicin, genistein, apigenin, luteolin, kaempferol, myricetin, quercetin, docosahexaenoic acid, quercetin, resveratrol, and ajoene, affect adipocytes during specific stages of development, resulting in either inhibition of adipogenesis or induction of apoptosis. Although numerous molecular targets that can be used for both treatment and prevention of obesity have been identified, targeted single cellular receptor or pathway has resulted in limited success. In this review, we discuss the state-of-the-art knowledge about antiobesity medicinal plants and their active compounds and their effects on several cellular, molecular, and metabolic pathways simultaneously with multiple phytochemicals through synergistic functioning which might be an appropriate approach to better management of obesity. In addition, epigenetic mechanisms (acetylation, methylation, miRNAs, ubiquitylation, phosphorylation, and chromatin packaging) of phytochemicals and their preventive and therapeutic perspective are explored in this review.

摘要

越来越多的研究表明,药用植物及其植物化学物质在预防和管理肥胖方面具有潜力,无论是单独使用还是协同使用。植物化学物质的多种组合可产生协同活性,在分子、细胞、代谢和时间水平上增强其有益效果,相对于基于化学合成药物的治疗方法具有优势。草药及其衍生化合物具有控制食欲、抑制胰脂肪酶活性、刺激产热和脂质代谢、增加饱腹感、促进脂肪分解、调节脂肪生成以及诱导脂肪细胞凋亡的潜力。此外,利用影响脂肪细胞生命周期不同阶段的各种膳食生物活性物质来靶向脂肪细胞生命周期,也是开发新型抗肥胖药物的一个重要靶点。在这方面,抗肥胖药物靶向的脂肪细胞发育的不同阶段可包括前脂肪细胞、成熟前脂肪细胞和成熟脂肪细胞。各种草药衍生的活性化合物,如辣椒素、染料木黄酮、芹菜素、木犀草素、山奈酚、杨梅素、槲皮素、二十二碳六烯酸、槲皮素、白藜芦醇和大蒜素,在特定发育阶段影响脂肪细胞,导致脂肪生成受到抑制或凋亡被诱导。尽管已经确定了许多可用于治疗和预防肥胖的分子靶点,但针对单一细胞受体或途径的效果有限。在本综述中,我们讨论了关于抗肥胖药用植物及其活性化合物的最新知识,以及它们通过协同作用同时对多种细胞、分子和代谢途径的影响,这可能是更好地管理肥胖的合适方法。此外,本综述还探讨了植物化学物质的表观遗传机制(乙酰化、甲基化、微小RNA、泛素化、磷酸化和染色质包装)及其预防和治疗前景。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a1a/8208872/21b89173cddb/ECAM2021-9995903.001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验